113 related articles for article (PubMed ID: 7628828)
1. Acute hemodynamic effects of combined inhibition of neutral endopeptidase and angiotensin converting enzyme in spontaneously hypertensive rats.
Pham I; Lévy B; Fournié-Zaluski MC; Poitevin P; Roques BP; Michel JB
Fundam Clin Pharmacol; 1995; 9(2):153-60. PubMed ID: 7628828
[TBL] [Abstract][Full Text] [Related]
2. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
Pham I; Gonzalez W; el Amrani AI; Fournié-Zaluski MC; Philippe M; Laboulandine I; Roques BP; Michel JB
J Pharmacol Exp Ther; 1993 Jun; 265(3):1339-47. PubMed ID: 8389863
[TBL] [Abstract][Full Text] [Related]
3. Triple vasopeptidase inhibition of angiotensin-converting enzyme/neutral endopeptidase/endothelin-converting enzyme activities on the hemodynamic profile of chronically instrumented unrestrained conscious spontaneously hypertensive rats.
Daull P; Blouin A; Sirois P; Nantel F; Jeng AY; Battistini B
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S398-401. PubMed ID: 15838331
[TBL] [Abstract][Full Text] [Related]
4. Effects of angiotensin-converting enzyme and neutral endopeptidase inhibitors: influence of bradykinin.
Pham I; Gonzalez W; Doucet J; Fournie-Zaluski MC; Roques BP; Michel JB
Eur J Pharmacol; 1996 Feb; 296(3):267-76. PubMed ID: 8904078
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme BMS-182657 in experimental hypertension and heart failure.
Trippodo NC; Robl JA; Asaad MM; Bird JE; Panchal BC; Schaeffer TR; Fox M; Giancarli MR; Cheung HS
J Pharmacol Exp Ther; 1995 Nov; 275(2):745-52. PubMed ID: 7473162
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic effects of long-term converting-enzyme inhibition in renal hypertensive rats.
Salom MG; Salazar FJ; Fenoy FJ; Pinilla JM; Marín N; Quesada T
Rev Esp Fisiol; 1990 Jun; 46(2):171-6. PubMed ID: 2274701
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the acute hypotensive effects of renin inhibition, converting enzyme inhibition, and angiotensin II antagonism in rats.
Wood JM; Mah SC; Schnell C
J Cardiovasc Pharmacol; 1990; 16 Suppl 4():S60-4. PubMed ID: 1705630
[TBL] [Abstract][Full Text] [Related]
8. Dual inhibition of neutral endopeptidase and angiotensin-converting enzyme in rats with hypertension and diabetes mellitus.
Tikkanen T; Tikkanen I; Rockell MD; Allen TJ; Johnston CI; Cooper ME; Burrell LM
Hypertension; 1998 Oct; 32(4):778-85. PubMed ID: 9774379
[TBL] [Abstract][Full Text] [Related]
9. Renal hemodynamic effects of nonhypotensive doses of angiotensin-converting enzyme inhibitors in hypertension and heart failure rats.
Nelissen-Vrancken HJ; Struijker-Boudier HA; Smits JF
J Cardiovasc Pharmacol; 1992 Feb; 19(2):163-8. PubMed ID: 1376783
[TBL] [Abstract][Full Text] [Related]
10. Effect of dual angiotensin converting enzyme/neutral endopeptidase inhibition, angiotensin converting enzyme inhibition, or AT1 antagonism on coronary microvasculature in spontaneously hypertensive rats.
Pu Q; Larouche I; Schiffrin EL
Am J Hypertens; 2003 Nov; 16(11 Pt 1):931-7. PubMed ID: 14573331
[TBL] [Abstract][Full Text] [Related]
11. Effects of combined AT1 receptor antagonist/NEP inhibitor on vascular remodeling and cardiac fibrosis in SHRSP.
Pu Q; Brassard P; Javeshghani DM; Iglarz M; Webb RL; Amiri F; Schiffrin EL
J Hypertens; 2008 Feb; 26(2):322-33. PubMed ID: 18192847
[TBL] [Abstract][Full Text] [Related]
12. In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats.
Yamamoto K; Chappell MC; Brosnihan KB; Ferrario CM
Hypertension; 1992 Jun; 19(6 Pt 2):692-6. PubMed ID: 1317352
[TBL] [Abstract][Full Text] [Related]
13. Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats.
Gonzalez Vera W; Fournié-Zaluski MC; Pham I; Laboulandine I; Roques BP; Michel JB
J Pharmacol Exp Ther; 1995 Jan; 272(1):343-51. PubMed ID: 7815350
[TBL] [Abstract][Full Text] [Related]
14. Hypotensive and hemodynamic effects of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
Shirota M; Iijima M; Ushijima T; Kajiwara Y; Kitabatake K
Arzneimittelforschung; 1990 Dec; 40(12):1303-9. PubMed ID: 2095126
[TBL] [Abstract][Full Text] [Related]
15. Prolonged inhibition of neutral endopeptidase 24.11 by sinorphan in stroke-prone spontaneously hypertensive rats.
Stasch JP; Knorr A; Wegner M; Hirth-Dietrich C
Hypertens Res; 1995 Jun; 18(2):137-43. PubMed ID: 7584920
[TBL] [Abstract][Full Text] [Related]
16. Neutral endopeptidase versus angiotensin converting enzyme inhibition in essential hypertension.
Favrat B; Burnier M; Nussberger J; Lecomte JM; Brouard R; Waeber B; Brunner HR
J Hypertens; 1995 Jul; 13(7):797-804. PubMed ID: 7594444
[TBL] [Abstract][Full Text] [Related]
17. Effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme, CGS 30440, on blood pressure and cardiac hypertrophy in spontaneously hypertensive rats.
Webb RL; Abramson ML; Beil ME; Odorico LM; Chatelain RE
J Cardiovasc Pharmacol; 1997 Nov; 30(5):632-42. PubMed ID: 9388046
[TBL] [Abstract][Full Text] [Related]
18. The first preclinical pharmacotoxicological safety assessment of CGS 35601, a triple vasopeptidase inhibitor, in chronically instrumented, conscious, and unrestrained spontaneously hypertensive rats.
Daull P; Lepage R; Benrezzak O; Cayer J; Beaudoin M; Belleville K; Blouin A; Sirois P; Nantel F; Jeng AY; Battistini B
Drug Chem Toxicol; 2006; 29(2):183-202. PubMed ID: 16707327
[TBL] [Abstract][Full Text] [Related]
19. Neutral endopeptidase inhibition augments vascular actions of bradykinin in patients treated with angiotensin-converting enzyme inhibition.
Cruden NL; Fox KA; Ludlam CA; Johnston NR; Newby DE
Hypertension; 2004 Dec; 44(6):913-8. PubMed ID: 15492133
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular status following combined angiotensin-converting enzyme and AT1 receptor inhibition in conscious spontaneously hypertensive rats.
Duke LM; Paull JR; Widdop RE
Clin Exp Pharmacol Physiol; 2003; 30(5-6):317-23. PubMed ID: 12859420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
